¹ßÇ¥Çü½Ä : Æ÷½ºÅÍ(Àü½Ã)
|
Á¢¼ö¹øÈ£ - 980018 OTPX-19 |
BONE DESTRUCTION IN CHRONIC OTITIS MEDIA IS NOT MEDIATED BY THE RANKL
PATHWAY OR ESTROGEN RECEPTOR-ALPHA |
1 DEPARTMENT OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, BUSAN PAIK HOSPITAL, BUSAN, SOUTH KOREA, 2 ANATOMY AND RESEARCH CENTER FOR TUMOR IMMUNOLOGY INJE UNIVERSITY COLLEGE OF MEDICINE, BUSAN PAIK HOSPITAL, BUSAN, SOUTH KOREA |
WOO JIN KIM,
KYUNG WOOK HEO1 , MINHYE NOH2 , DAE YOUNG HUR2 , TAE UI HONG1 , SUNG YOOL PARK1 AND WOO JIN KIM1
|
¸ñÀû: Chronic otitis media with or without cholesteatoma progresses with
various degrees of bone resorption and remodeling. Estrogen mediates
osteoprotective effects through the receptor activator of NF-¥êB
ligand (RANKL) pathway, which is mainly mediated by estrogen receptor-
alpha (ER-¥á). The present study investigated the expression patterns
of receptor activator of NF¥êB (RANK), osteoprotegerin (OPG), RANKL,
and ER-¥á in pathological tissue from patients with chronic otitis
media to determine the roles of those factors in osteolytic mechanisms
underlying the pathogenesis of chronic otitis media. ¹æ¹ý:Normal and pathological specimens from 18 patients with chronic otitis
media were examined. °á°ú:There were no significant differences in RANK, OPG, RANKL, or ER-¥á mRNA
expression between normal and pathological specimens of epithelial
tissue °á·Ð:Our findings suggested that RANK, OPG, RANKL, and ER-¥á are not
associated with the bone destruction in chronic otitis media; other
cytokines may directly activate the osteoclasts in chronic otitis
media. |
|